ClassID:

170810

G01N2800/101 - CPC Classification

Classification description:

Detection or diagnosis of diseases; Musculoskeletal or connective tissue disorders Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis

Sub-classes:
Recent Application in this class:
#1
20260118356
2026-04-30

NOVEL AUTO-ANTIBODIES AND METHOD TO DETECT SJÖGREN'S DISEASE

#2
20250334574
2025-10-30

Autoantibody Biomarkers of Ro/SS-A Antibody Negative Sjogren's Syndrome/Sjogren's Disease

#3
20250012796
2025-01-09

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS OF SYSTEMIC AUTOIMMUNE DISEASE

#4
20240201185
2024-06-20

MARKERS OF AUTOIMMUNE DISEASES

#5
20230242636
2023-08-03

MONOCLONAL ANTIBODIES TARGETED TO HUMAN TAXILIN ALPHA AND METHODS FOR USE OF SAME

#6
20230152313
2023-05-18

Antibody Tests for Identifying RO Negative Sjogren's Syndrome and Use as Biomarkers for Dysregulated B Cell Responses, B Cell Lymphoma, Tissue Fibrosis and Salivary Gland Dysfunction

#7
20230110385
2023-04-13

NON-INVASIVE DETECTION OF SALIVARY AUTOANTIBODIES

#8
20230043394
2023-02-09

METHODS FOR DETECTION OF PATHOGENIC ANTIPHOSPHOLIPID ANTIBODIES AND FOR IDENTIFICATION OF INHIBITORS

#9
20220163524
2022-05-26

METHODS, ARRAYS AND USES THEREOF FOR DIAGNOSING OR DETECTING AN AUTOIMMUNE DISEASE

#10
20210405047
2021-12-30

ANTI-CARBAMYLATED PROTEIN ANTIBODIES AND THE RISK FOR ARTHRITIS

#11
20210139577
2021-05-13

LEVELS OF BCMA PROTEIN EXPRESSION ON B CELLS AND USE IN DIAGNOSTIC METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS

#12
20200408780
2020-12-31

DIAGNOSTIC FOR SJORGREN'S SYNDROME BASED ON A BIOMARKER

#13
20200110087
2020-04-09

ANTI-CARBAMYLATED PROTEIN ANTIBODIES AND THE RISK FOR ARTHRITIS

#14
20190233508
2019-08-01

Methods of detecting human IL-21

#15
20190195888
2019-06-27

Identification and monitoring of cleaved immunoglobulins by molecular mass

#16
20190004044
2019-01-03

Anti-carbamylated protein antibodies and the risk for arthritis

#17
20180298094
2018-10-18

MONOCLONAL ANTIBODIES TARGETED TO HUMAN TAXILIN ALPHA AND METHODS FOR USE OF SAME

#18
20180209961
2018-07-26

METHODS FOR DETERMINING DRUG EFFICACY USING CEREBLON-ASSOCIATED PROTEINS

#19
20180080082
2018-03-22

Compositions and methods for sjögren's syndrome

#20
20180064828
2018-03-08

Methods for the diagnosis and treatment of Sjögren's syndrome

#21
20170285027
2017-10-05

METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT

#22
20170199187
2017-07-13

COMPOSITIONS AND METHODS FOR THE DIAGNOSIS OF SYSTEMIC AUTOIMMUNE DISEASE

#23
20150273083
2015-10-01

Methods for the diagnosis and treatment of sjögren's syndrome

#24
20150010584
2015-01-08

Targeted Delivery Of Autoantigens To B Cell Populations

#25
20140363829
2014-12-11

Method for increasing specificity of diagnostic tests for autoimmune diseases

#26
20140255955
2014-09-11

Method of diagnosing Sjogren's disease

#27
20140220014
2014-08-07

Levels of BCMA protein expression on B cells and use in methods of treating systemic lupus erythematosus

#28
20140162297
2014-06-12

Anti-carbamylated protein antibodies and the risk for arthritis

#29
20140162282
2014-06-12

Methods for determining drug efficacy using cereblon-associated proteins

#30
20140134644
2014-05-15

Methods and kits for diagnosing Sjögren's syndrome

#31
20130310273
2013-11-21

Methods and means for diagnosing vasculitis

#32
20130040322
2013-02-14

Method of diagnosing Sjogren's disease

#33
20120328567
2012-12-27

BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO IFNB AND USES THEREOF

#34
20120283122
2012-11-08

Analyte quantification multiplex microarrays combining internal and external calibration

#35
20120058119
2012-03-08

HUMAN TUMOR NECROSIS FACTOR TR21 AND METHODS BASED THEREON

#36
20120020970
2012-01-26

Method of treating lupus nephritis

#37
20120015992
2012-01-19

Naphthalene-based inhibitors of anti-apoptotic proteins

#38
20120004311
2012-01-05

Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)

#39
20110300529
2011-12-08

DETECTION OF IFI16 IN BODY FLUIDS

#40
20110287456
2011-11-24

Synthetic peptides, methods and kits for diagnosing autoimmune diseases

#41
20100297676
2010-11-25

METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT

#42
20100267781
2010-10-21

Naphthalene-based inhibitors of anti-apoptotic proteins

#43
20100178652
2010-07-15

Materials and Methods for the Detection, Prevention and Treatment of Autoimmune Disease

#44
20100075348
2010-03-25

Method for diagnosis of a disease involving an anti-endothelin-receptor antibody

#45
20100040624
2010-02-18

Human Tumor Necrosis Factor TR21 and Methods Based Thereon

#46
20100035360
2010-02-11

REAGENT FOR DETECTION OF AUTOANTIBODY AND KIT FOR DIAGNOSIS OF AUTOIMMUNE DISEASE

#47
20100021906
2010-01-28

Salivary biomarkers for Sjögren's syndrome

#48
20100015055
2010-01-21

PRETREATMENT OF A BIOLOGICAL SAMPLE FROM AN AUTOIMMUNE DISEASE SUBJECT

#49
20090325196
2009-12-31

LEVELS OF BCMA PROTEIN EXPRESSION ON B CELLS AND USE IN DIAGNOSTIC METHODS

#50
20080292622
2008-11-27

Measurement of soluble Tweak levels for evaluation of lupus patients

#51
20080171344
2008-07-17

Methods, Kits and Materials for Diagnosing Disease States by Measuring Isoforms or Proforms of Myeloperoxidase

#52
20080058271
2008-03-06

Prevention of primary sjogren' s Syndrome by ICA69 deficiency

#53
20070184502
2007-08-09

Method of diagnosing Sjogren's syndrome

#54
20070009521
2007-01-11

Human tumor necrosis factor TR21 and methods based thereon

#55
20060263349
2006-11-23

Pretreatment of a biological sample from an autoimmune disease subject

#56
20060074022
2006-04-06

Prevention of primary Sjogren's Syndrome by ICA69 deficiency

#57
20050260680
2005-11-24

Methods of diagnosing and treating autoimmune diseases

#58
20050042689
2005-02-24

Diagnosing sjogren's syndrome